Research programme: vitamin D3 derivatives - Astellas Pharma
Alternative Names: 1,25-D3 antagonists - Astellas; DLAM derivatives - Astellas; Vitamin D3 derivatives - AstellasLatest Information Update: 16 Jul 2016
At a glance
- Originator Astellas Pharma
- Class
- Mechanism of Action Vitamin D3 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Bone disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Bone-disorders in Japan
- 03 Jul 2006 Preclinical trials in Bone disorders in Japan (unspecified route)